Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹24,984 Cr
Revenue (TTM)
₹7,896 Cr
Net Profit (TTM)
₹681 Cr
ROE
19.5 %
ROCE
19.9 %
P/E Ratio
36.7
P/B Ratio
5.6
Industry P/E
38.93
EV/EBITDA
16.6
Div. Yield
0.2 %
Debt to Equity
0
Book Value
₹234.6
EPS
₹36.7
Face value
10
Shares outstanding
189,508,347
CFO
₹6,162.23 Cr
EBITDA
₹10,048.83 Cr
Net Profit
₹3,775.94 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Emcure Pharmaceuticals
| -8.4 | 24.5 | 41.4 | -- | -- | -- | -- |
|
BSE Healthcare
| -5.4 | 0.7 | 5.6 | 15.1 | 26.7 | 21.5 | 10.3 |
|
BSE Mid Cap
| -3.1 | -0.1 | 11.8 | -2.8 | 28.3 | 28.8 | 15.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Emcure Pharmaceuticals
|
1,325.5 | 24,983.8 | 7,896.0 | 707.5 | 13.8 | 16.1 | 36.7 | 5.6 |
| 439.8 | 4,006.8 | 2,387.0 | 168.1 | 9.7 | 12.7 | 23.8 | 2.9 | |
| 1,000.8 | 12,336.5 | 2,386.9 | 485.6 | 26.1 | 18.1 | 25.4 | 4.4 | |
| 856.1 | 14,832.2 | 1,030.0 | 305.2 | 34.9 | 29.7 | 48.6 | 13.1 | |
| 1,973.3 | 20,559.2 | 1,200.1 | 373.0 | 37.7 | 21.8 | 55.3 | 11.3 | |
| 6,493.0 | 1,72,374.1 | 9,360.0 | 2,191.0 | 27.4 | 15.3 | 78.7 | 11.5 | |
| 12,211.0 | 15,706.5 | 1,476.8 | 260.1 | 17.5 | 13.7 | 60.4 | 10.3 | |
| 2,416.7 | 4,001.1 | 653.4 | 183.2 | 21.2 | 20.9 | 21.8 | 7.5 | |
| 226.2 | 4,942.6 | 6.7 | -160.8 | -2,578.1 | -106.2 | -- | 44.9 | |
| 570.2 | 3,946.2 | 2,028.9 | 150.6 | 7.5 | 6.2 | 28.7 | 1.6 |
5 min read•By Hemkesh Khattar
--
Incorporated
1981
Chairman
Berjis Minoo Desai
Managing Director
Satish Ramanlal Mehta
Headquarters
Pune, Maharashtra
Website
Looking for more details about Emcure Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Emcure Pharmaceuticals Ltd stood at ₹ 8,233 Cr as on 31-Mar-25
The share price of Emcure Pharmaceuticals Ltd is ₹1,325.50 (NSE) and ₹1,326.45 (BSE) as of 19-Jun-2025 15:47 IST. Emcure Pharmaceuticals Ltd has given a return of --% in the last 1 years.
Emcure Pharmaceuticals Ltd has a market capitalisation of ₹ 24,984 Cr as on 19-Jun-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Emcure Pharmaceuticals Ltd is 5.62 times as on 19-Jun-2025, a 75% premium to its peers’ median range of 3.21 times.
The P/E ratio of Emcure Pharmaceuticals Ltd is 36.67 times as on 19-Jun-2025, a 6% discount to its peers’ median range of 38.93 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Emcure Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Emcure Pharmaceuticals Ltd.
The prominent promoters of Emcure Pharmaceuticals Ltd are
| Name of promoters | Holding percentage |
|---|---|
|
Satish R Mehta |
39.79%
|
|
Unity Trust (Shares held by Sunil RajanikantMehta with Kamini Sunil Mehta, as trustees) |
7.66%
|
|
Everest Trust (Shares held by SanjayRajanikant Mehta with Sonali Sanjay Mehta,as trustees) |
7.66%
|
|
Samit S Mehta |
7.14%
|
The chairman of the company is Berjis Minoo Desai, and the managing director is Satish Ramanlal Mehta.
The promoters of Emcure Pharmaceuticals Ltd have pledged 0.03% of the total equity as on Mar-25.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
22,080
|
|
|
16,923
|
|
|
16,554
|
|
|
12,424
|
|
|
1,77,076
|
|
|
5,139
|
|
|
4,280
|
|
|
4,235
|
|
|
3,869
|
| Emcure Pharmaceuticals Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
16.09
|
|
Operating margin(%)
|
13.81
|
|
Net Margin(%)
|
8.88
|
|
Dividend yield(%)
|
0.22
|
Yes, TTM profit after tax of Emcure Pharmaceuticals Ltd was ₹681 Cr.
₹-13.40
(
